公司资料
Idera 股价、新闻与催化剂
- 股票代码:
- IDRA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for IDRA.
公司概览
业务概览
Idera Pharmaceuticals is a historical small-cap biotechnology name associated with immunology and oncology programs, including work around innate immune pathways. The company has long been a legacy example of a narrow pipeline trying to create value in a very competitive biotech market.
所在地与行业分类
Idera is headquartered in the United States and listed on NASDAQ, with a profile that has historically sat in small-cap biotech. It belongs more to the legacy development group than to a large commercial franchise.
商业模式特征
The business model was defined by clinical development, capital preservation, and the ability to keep a focused pipeline alive long enough to generate value. Investors historically watched data updates, restructuring activity, and financing runway.
生物医药行业定位
Idera sits in the historical category of high-risk micro-cap biotech names. It is best understood as a legacy development story where execution and financing risk were always dominant.
未来催化剂
- Idera is now largely a legacy / closeout story, so the catalysts are any asset-resolution update rather than a live pipeline readout. The company is mainly in wind-down mode.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。